QQ客服 官方微博 反馈留言

	A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor alpha
	Ning, Yang; Chen, Haifei; Du, Yongli; Ling, Hao; Zhang, Liudi; Chen, Lu; Qi, Huijie; Shi, Xiaojin; Li, Qunyi
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2017
卷号	93
关键词	Estrogen-related receptor a Triple negative breast cancer Inverse agonist
ISSN号	0753-3322
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3617997
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Ning, Yang,Chen, Haifei,Du, Yongli,et al. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor alpha[J]. BIOMEDICINE & PHARMACOTHERAPY,2017,93.
APA	Ning, Yang.,Chen, Haifei.,Du, Yongli.,Ling, Hao.,Zhang, Liudi.,...&Li, Qunyi.(2017).A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor alpha.BIOMEDICINE & PHARMACOTHERAPY,93.
MLA	Ning, Yang,et al."A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor alpha".BIOMEDICINE & PHARMACOTHERAPY 93(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。